Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest

Paul Moss; Francis Berenbaum; Giuseppe Curigliano; Ayelet Grupper; Thomas Berg; Shanti Pather

doi:10.1016/j.vaccine.2022.05.067

Journal Articles Vaccine Year : 2022

Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest

, (1) , , , ,

1

Paul Moss

Function : Author

Francis Berenbaum

Function : Author
PersonId : 15361
IdHAL : francis-berenbaum
ORCID : 0000-0001-8252-7815
IdRef : 089286774

Centre de Recherche Saint-Antoine

Giuseppe Curigliano

Function : Author

Ayelet Grupper

Function : Author

Thomas Berg

Function : Author

Shanti Pather

Function : Author

Domains

Life Sciences [q-bio]

francis berenbaum : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03994741

Submitted on : Friday, February 17, 2023-4:17:51 PM

Last modification on : Monday, March 4, 2024-10:42:22 AM

Dates and versions

hal-03994741 , version 1 (17-02-2023)

Identifiers

HAL Id : hal-03994741 , version 1
DOI : 10.1016/j.vaccine.2022.05.067

Cite

Paul Moss, Francis Berenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, et al.. Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest. Vaccine, 2022, 40 (32), pp.4348-4360. ⟨10.1016/j.vaccine.2022.05.067⟩. ⟨hal-03994741⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

U938 SORBONNE-UNIVERSITE SU-MEDECINE

7 View

0 Download

Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share